mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
L’ASSOMPTION, Quebec, Dec. 24, 2021 -- Terranueva Corporation (CSE: TEQ) ("Terranueva") is pleased to announce it has agreed to $133,333 in principal amount of convertible debenture (the “Debentures”) maturing on March 31, 2023, convertible into common shares of the capital stock of Terranueva at a conversion price of $0.15 per share subj... Read More...
MONTREAL, Nov. 02, 2020 -- Terranueva Corporation (CSE: TEQ) (“Terranueva” or the “Company”). The Board of Directors of Terranueva announced today a new organizational structure. Mr. Peter Polatos is appointed as interim President and Chief Executive Officer for the entire organization and also becomes a director of the Company."I am deli... Read More...
STOCK MARKET SYMBOL: TEQ
L'ASSOMPTION, QC, Oct. 5, 2020 /CNW Telbec/ - Terranueva Corporation (CSE: TEQ) ("Terranueva"), one of six Quebec companies holding a license from Health Canada to develop cannabis-based medicinal products, is pleased to announce that the CED has granted a $500,000 repayable contribution to the Company in support ... Read More...
L’ASSOMPTION, Quebec, July 15, 2020 -- CORPORATION TERRANUEVA (CSE : TEQ) (the “Corporation” or “Terranueva”) and Laboratoire LSL Inc. ("Laboratoire LSL") announce that the parties have terminated their contractual relationship for the acquisition of the securities of Laboratoire LSL announced by press release on March 27, 2020.The Corpor... Read More...
L’ASSOMPTION, Quebec, March 27, 2020 -- CORPORATION TERRANUEVA (CSE : TEQ) (the “Corporation” or “Terranueva”) announces that it has reached a preliminary agreement, which became effective on March 26, 2020 following the consent of the two main creditors of Terranueva, with the owners of the pharmaceutical company LSL Laboratory Inc. (“LS... Read More...
MONTREAL, Dec. 11, 2019 -- Corporation Terranueva (CSE: TEQ) ("Terranueva") announces the closing of a secured $2M revolving credit facility (the "Revolving Credit") with a lending institution. Under the terms of the Revolving Credit, the funds will be used to finance the activities of its subsidiary, Terranueva Pharma Corporation, to fin... Read More...
L’ASSOMPTION, Quebec, July 17, 2019 -- Corporation Terranueva (CSE:TEQ) ("Terranueva") is pleased to announce the completion of its first harvest in its certification, research and development unit ("CRDU")."We are very pleased with the first results, the yield is higher than we expected, which allows us to confirm that our growing method... Read More...
L'ASSOMPTION, Quebec, April 16, 2019 -- Terranueva Corporation (CSE:TEQ) ("Terranueva" or the "Corporation") is pleased to announce that it is joining the Quebec Cannabis Industry Association (QCIA) as Founding Member. By taking an active role on the QCIA Board of Directors, Terranueva shows it is fully committed to a strong cannabis indu... Read More...
MONTRÉAL, April 15, 2019 -- Terranueva Corporation (CSE:TEQ) ("Terranueva" or the "Corporation") is pleased to announce that, following the issuance of culture, transformation and sale (medical) licenses issued by Health Canada on February 22, the Company pursued its development plan by securing contingent options to purchase over 280,000... Read More...
MONTREAL, Feb. 27, 2019 -- TERRANUEVA CORPORATION (“Terranueva”) (CSE:TEQ) announces that it has raised $278,743.04 from its rights offering (the “Rights”), which started on October 30, 2018, while holders have exercised Rights at $0.64 each to acquire an aggregate of 435,536 common shares in the capital stock of Terranueva, of which none... Read More...
MONTRÉAL, Feb. 19, 2019 -- TERRANUEVA CORPORATION (“Terranueva” or the “Company”) is pleased to announce that it has completed a private placement for an aggregate amount of $366,666 in common shares at a price of $0.50 per share, representing an aggregate of 733 332 shares of the capital stock of Terranueva. This private placement comes ... Read More...
MONTRÉAL, Feb. 05, 2019 -- TERRANUEVA CORPORATION (“Terranueva” or the “Company”) announces the grant to its directors, officers, employees and consultants of an aggregate of 2,225,000 stock options to acquire the same number of common shares of the capital stock of the Corporation at an exercise price $0.50 per share for a period between... Read More...
MONTREAL, Dec. 17, 2018 -- Terranueva Corporation (the “Corporation” or “Terranueva”) (TEQ.CN) is pleased to announce the closing of a private placement and of the transaction of $10 930 000 with Terranueva Pharma Corporation (“Terranueva Pharma”) consisting of a reverse takeover between the shareholders of Terranueva Pharma and Axe Explo... Read More...
